Akoya Biosciences Inc (AKYA)
3.82
+0.01
(+0.26%)
USD |
NASDAQ |
Apr 25, 16:00
3.82
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Total Long Term Debt (Quarterly): 75.25M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 75.25M |
September 30, 2023 | 63.82M |
June 30, 2023 | 63.64M |
March 31, 2023 | 63.46M |
December 31, 2022 | 63.28M |
September 30, 2022 | 52.71M |
June 30, 2022 | 42.56M |
March 31, 2022 | 32.58M |
Date | Value |
---|---|
December 31, 2021 | 32.47M |
September 30, 2021 | 32.36M |
June 30, 2021 | 32.26M |
March 31, 2021 | 34.63M |
December 31, 2020 | 34.52M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
75.25M
Maximum
Dec 2023
38.97M
Average
34.57M
Median
Total Long Term Debt (Quarterly) Benchmarks
Bruker Corp | 1.282B |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 36.56M |
Bionano Genomics Inc | 69.80M |
Singular Genomics Systems Inc | 8.901M |